Monkeypox spreads to Europe and North America as cases multiply across Portugal and Spain

Multiple individuals hospitalized in Portugal and Spain with confirmed or suspected monkeypox infections requiring medical observation.
The virus had learned to travel.
Monkeypox, confined to Africa for fifty years, suddenly appeared across Europe and North America in May 2022.

Un virus conocido desde 1958, pero confinado durante décadas a regiones específicas de África, comenzó a aparecer en mayo de 2022 en Europa y América del Norte, desafiando las fronteras geográficas que habían limitado su alcance. Portugal, España y Estados Unidos confirmaron casos en cuestión de días, obligando a las autoridades sanitarias mundiales a reconsiderar la naturaleza y el alcance de una amenaza que, hasta entonces, parecía distante. La viruela del mono —mal nombrada, pues son los roedores salvajes y no los primates quienes la transmiten principalmente— recordó al mundo que los patógenos no respetan las narrativas de contención que los seres humanos construyen a su alrededor.

  • En cuestión de días, lo que parecía un brote contenido en África se convirtió en una alerta sanitaria simultánea en Portugal, España y Estados Unidos, con decenas de casos confirmados o sospechosos.
  • España pasó de ocho personas bajo observación a veintitrés en cuestión de horas, mientras Portugal hospitalizaba a nueve pacientes, evidenciando una velocidad de expansión que tomó por sorpresa a los sistemas de salud.
  • Las autoridades sanitarias de múltiples países activaron protocolos de rastreo de contactos y vigilancia epidemiológica ante la posibilidad de que el virus hubiera encontrado nuevas vías de transmisión en poblaciones sin inmunidad previa.
  • La pregunta ya no era si la viruela del mono podía llegar a Occidente —ya lo había hecho— sino hasta dónde llegaría y con qué velocidad, dejando a los organismos de salud global en un estado de alerta cautelosa pero urgente.

A mediados de mayo de 2022, los sistemas de salud de Europa y América del Norte comenzaron a registrar algo inesperado: casos de viruela del mono, una enfermedad que durante décadas había permanecido confinada principalmente a África. Los síntomas —fatiga, fiebre, ganglios inflamados y erupciones cutáneas— empezaron a aparecer en personas que no habían viajado a las regiones donde el virus era endémico.

El 7 de mayo, Europa confirmó su primer caso. Portugal identificó rápidamente a cinco hombres de entre 20 y 50 años, y para el 18 de mayo ya eran catorce los pacientes confirmados, con nueve hospitalizados. España colocó bajo observación a veintitrés personas sospechosas en ese mismo período. Estados Unidos, por su parte, confirmó su primer caso, cerrando el círculo de una expansión que ya abarcaba dos continentes.

El nombre del virus guarda una ironía histórica: fue identificado en 1958 en colonias de primates usados en investigación clínica, de ahí su denominación. Sin embargo, son los roedores salvajes —ardillas, ratas gigantes de Gambia, lemures enanos africanos— quienes constituyen el principal reservorio y vector de transmisión. El virus pertenece al género Orthopoxvirus, familia que incluye también al agente causante de la viruela humana.

El primer caso humano documentado data de 1970, cuando un niño de doce años en la República Democrática del Congo fue diagnosticado. Desde entonces, el virus circuló de forma endémica en países de África Central y Occidental, con apariciones esporádicas en Asia. Durante décadas, la geografía actuó como barrera natural.

La primavera de 2022 rompió ese patrón. La aparición simultánea de casos en múltiples países occidentales sugería que el virus había encontrado nuevos caminos. Las autoridades sanitarias globales pasaron al modo de vigilancia activa, conscientes de que la pregunta ya no era si el virus había cruzado fronteras, sino hasta dónde llegaría.

The symptoms arrive quietly at first—exhaustion, chills, muscle aches—then build into something harder to ignore: fever, headache, swollen lymph nodes, and a rash that spreads across the skin. By mid-May 2022, these signs had begun appearing in people across Europe and North America, triggering health alerts in multiple countries and forcing officials to confront a virus that had, until recently, remained largely confined to Africa.

On May 7, Europe recorded its first confirmed case of monkeypox. The discovery set off a chain reaction. Within days, Portugal reported five men between 20 and 50 years old testing positive. By May 18, that number had jumped to fourteen confirmed patients, with nine additional men requiring hospitalization. Spain, meanwhile, placed eight people under observation for suspected infection on the same day—a figure that climbed to twenty-three within hours. Across the Atlantic, the United States confirmed its first case, marking the virus's arrival on the North American continent.

The name itself carries a historical quirk. When American health officials first identified the virus in 1958, they found it in colonies of primates being used for clinical research. The discovery led naturally to the name monkeypox, a label that has stuck for more than six decades. Yet the terminology is misleading. Wild rodents—not monkeys—are the primary carriers and spreaders of the disease. The actual list of animals capable of transmitting the virus includes squirrels, African dwarf lemurs, giant Gambian rats, and primates, but the rodents bear the heaviest burden of transmission.

The virus itself belongs to a genus called Orthopoxvirus, part of the larger Poxviridae family. This family includes three significant variants: the variola virus, which causes smallpox; vaccinia virus; and the monkeypox virus itself. The distinction matters because these are serious pathogens with a documented history of human infection.

The first human case emerged twelve years after the virus was discovered. In 1970, a twelve-year-old boy in the Democratic Republic of Congo became the first confirmed human patient. From that initial case, the virus established itself in pockets across Central and West Africa—Cameroon, Ivory Coast, Gabon, Liberia, Nigeria, Sierra Leone—and eventually reached Asia, appearing in Singapore. For decades, monkeypox remained largely a disease of specific regions, contained by geography and circumstance.

But the spring of 2022 marked a turning point. The simultaneous emergence of cases across Portugal, Spain, and the United States suggested the virus had found new pathways of transmission, new populations to infect, new territories to occupy. Health authorities in multiple nations shifted into monitoring mode, tracking the spread, identifying contacts, and preparing for scenarios that, weeks earlier, would have seemed unlikely. The question was no longer whether monkeypox could reach Europe and North America—it had. The question now was how far it would go.

Wild rodents are the primary carriers and spreaders of the disease, not monkeys, despite the virus's name.
— U.S. health officials
The Hearth Conversation Another angle on the story
Inventor

Why did this virus suddenly appear in Europe and North America in May 2022, when it had been confined to Africa for decades?

Model

The source doesn't explain the mechanism of spread—whether it was travel, trade, or some other vector. What we know is that it happened. The virus crossed a threshold it hadn't crossed before, and multiple countries detected cases almost simultaneously.

Inventor

The name monkeypox is misleading, then. Rodents do most of the spreading?

Model

Exactly. The name comes from where it was discovered—in lab primates in 1958—but that's almost an accident of history. Wild rodents are the real reservoir. Squirrels, rats, lemurs. The monkeys got the name, but the rodents do the work.

Inventor

A twelve-year-old was the first human case. How did he get infected?

Model

The source doesn't say. We only know it happened in the Democratic Republic of Congo in 1970, twelve years after the virus was identified. After that, it stayed mostly in Central and West Africa for fifty years.

Inventor

What changed in 2022?

Model

That's the unsettling part. We don't know from this reporting. But suddenly Portugal had fourteen cases, Spain had dozens under observation, and the United States had its first confirmed patient. The virus had learned to travel.

Inventor

Are these serious infections?

Model

Serious enough that people were being hospitalized. The symptoms—fever, swollen lymph nodes, rash—they're real and they're debilitating. But the source doesn't tell us about severity or mortality rates. It just tells us people were sick enough to need medical care.

Contact Us FAQ